Sanofi Pasteur has a wide range of standalone and combination vaccines that protect against multiple diseases in a single injection. Some of our paediatric vaccines are used in over 100 countries worldwide.

VidPrevtyn Beta is a monovalent, recombinant-protein next-generation COVID-19 vaccine developed by Sanofi, modelled on the Beta variant and including GSK's pandemic adjuvant. The same recombinant-protein technology is used in Sanofi's approved seasonal flu vaccines.

Menactra Menactra is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menactra is approved for use in individuals 9 months through 55 years of age.

Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines.

Commonly Used Sanofi Products While Sanofi may be best known as the manufacturer of Ambien, the company makes many other commonly used medicines and over-the-counter products.

For over 2 centuries, people have been vaccinated against deadly diseases, ever since the world's first vaccine was devised against smallpox.

The Sanofi vaccine, known as VidPrevtyn Beta, is protein-based and instead contains copies of the SARS-CoV-2 spike protein from the beta variant.

We executed an extensive development program which was based on innovative and proven manufacturing technology to make our protein-based adjuvanted COVID-19 booster vaccine available for use in Europe. Our COVID-19 vaccine was developed in partnership with GSK and US BARDA.

Meningococcal Vaccination There are 2 types of meningococcal vaccines available in the United States: Meningococcal conjugate or MenACWY vaccines (Menactra®, Menveo®, and MenQuadfi®) Serogroup B meningococcal or MenB vaccines (Bexsero®and Trumenba®)

What Types of Meningococcal Vaccines Are There?

• MenACWY (conjugate) vaccines (Menactra®, Menveo®, and MenQuadfi®)
• MenB (recombinant protein) vaccines (Bexsero® and Trumenba®)

Sanofi Pasteur produces influenza vaccines each year across five international sites: Swiftwater (Pennsylvania, United States), Pearl River (New York, United States), Val-de-Reuil (France), Ocoyoacac (Mexico) and Shenzhen (China). This makes Sanofi Pasteur the largest manufacturer of influenza vaccines in the world.

History. The Sanofi–GSK COVID‑19 vaccine is under development by the French pharmaceutical company Sanofi and the British-American pharmaceutical company GlaxoSmithKline.